Seeking Alpha

svygear » Comments |

Sort by:
Latest | Highest rated
  • Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer [View article]
    you mention PARD, another company working on a new and improved platinum drug is ACCP: griffinsecurities.com/...
    Jun 19 15:50 pm |Rating: 0 -1 |Link to Comment
  • Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline [View article]
    check ACCP, another cancer and diversified pipeline play. griffinsecurities.com/...
    Jun 19 15:47 pm |Rating: +1 -3 |Link to Comment
  • BioDelivery Sciences: More than a One Drug Company [View article]
    ACCP's oral insulin provides a pharmacological response (lowering of blood glucose levels in an animal model of diabetes) equivalent to 90% of that achieved by insulin delivered subcutaneously. Major biopharmaceutical companies evaluating the technology for potential applications for oral delivery of insulin, hGH, siRNA and monoclonal antibodies: pitch.pe/15552
    Jun 17 15:09 pm |Rating: 0 0 |Link to Comment
  • Amylin, Biogen Idec Stand to Benefit from Icahn Board Victories [View article]
    Another diabetes play - ACCP:
    ACCP's oral insulin provides a pharmacological response (lowering of blood glucose levels in an animal model of diabetes) equivalent to 90% of that achieved by insulin delivered subcutaneously. Major biopharmaceutical companies evaluating the technology for potential applications for oral delivery of insulin, hGH, siRNA and monoclonal antibodies: pitch.pe/15552
    Jun 17 14:50 pm |Rating: 0 0 |Link to Comment
  • FDA Calendar Updates: BioDelivery Sciences Worth the Wait  [View article]
    ACCP's oral insulin provides a pharmacological response (lowering of blood glucose levels in an animal model of diabetes) equivalent to 90% of that achieved by insulin delivered subcutaneously. Major biopharmaceutical companies evaluating the technology for potential applications for oral delivery of insulin, hGH, siRNA and monoclonal antibodies: pitch.pe/15552
    Jun 17 14:48 pm |Rating: +1 0 |Link to Comment
  • Access Pharmaceuticals: Gaining Momentum  [View article]
    BioMedReports also wrote up about ACCP: seekingalpha.com/artic...
    Jun 12 12:21 pm |Rating: 0 0 |Link to Comment
  • Dendreon: Charting the Course to Big Profits [View article]
    Stockhaven.com put a good primer on ACCP.OB: www.stockshaven.com/ga.../
    Jun 11 14:12 pm |Rating: 0 -2 |Link to Comment
  • Access Pharma: Preparing to Advance Pipeline [View article]
    StockHaven.com also wrote up about ACCP:
    www.stockshaven.com/ga.../

    seekingalpha.com/artic...
    Jun 11 14:04 pm |Rating: +2 0 |Link to Comment
  • Friday's BioPlay: Xoma Ltd. [View article]
    Pharma Play: Access Pharmaceuticals (ACCP)

    Press Release:
    pitch.pe/14217

    Regards,
    svygear
    Jun 08 16:01 pm |Rating: 0 0 |Link to Comment
  • XTENT Extends a Lesson in Shorting Biotechs [View article]
    Not exactly sure if shorting is the way to go about things....

    Take a look at Access Pharmaceuticals (ACCP) for instance...they have a press release that may prove to be pretty valuable for a lot of you skeptics out there...

    pitch.pe/14217
    Jun 08 15:59 pm |Rating: 0 0 |Link to Comment
  • Picking the Wrong Horse? Accentia vs. Biovest [View article]
    Great article... but I think I have a solid pharma play in Access Pharmaceuticals. Press Release Here:
    pitch.pe/14217

    Ticker: ACCP
    Jun 08 15:55 pm |Rating: 0 0 |Link to Comment
  • Insmed Stock Rising on High Volume, But Still a Good Buy [View article]
    Great article....

    But I also wanted to add some "insight" of my own and suggest another solid pharma play in Access Pharmaceuticals (ACCP) whose recent press-release regarding some very interesting news can be seen here:
    pitch.pe/14217
    Jun 08 15:53 pm |Rating: 0 0 |Link to Comment
  • Health Care Trends Part 2: M&A, Generic Competition, CROs [View article]
    I just wanted to add some value-added info to this comment board as well.

    A solid up-and-coming pharmaceutical play is Access Pharmaceuticals (ACCP), whose most recent press release can be viewed at pitch.pe/14217

    Just wanted to add that they have a new Thiarabine-clofarabine combination study which has proven to be some pretty revolutionary and interesting stuff..... might wanna check it out
    Jun 08 15:50 pm |Rating: 0 0 |Link to Comment
  • Life Science Companies Get Boost from Capital Markets [View article]
    Excellent article, Mr. Burrill.

    I also had a solid pharmaceutical play for all of you investors out there. Another oncology-related stock that was brought to my attention recently, ACCESS PHARMACEUTICALS, which now has a press release regarding THIARABINE COMBINATION that can be viewed at:
    pitch.pe/14217

    Please note that the ticker for this particular oncology stock is: ACCP.

    Regards,
    svygear
    Jun 08 15:46 pm |Rating: 0 0 |Link to Comment
  • Why I'm Not Buying Biovest... Yet [View article]
    Why I'm Buying *Access Pharma*... Now

    After reading this article, I was reminded of another oncology-related stock that was brought to my attention recently, ACCESS PHARMACEUTICALS, which now has a press release regarding THIARABINE COMBINATION that can be viewed at:
    pitch.pe/14217

    Please note that the ticker for this particular oncology stock is: ACCP.

    Regards,
    svygear
    Jun 08 15:44 pm |Rating: 0 0 |Link to Comment
Comments by Ticker
svygear's
Comments Stats
29 comments
Rating: -4 (8 - 12 )